Patent · US Active

Indolylmaleimide derivatives

US7825124B2 · kind B2 · utility

1Cited by

8References

3Claims

0Family size

Inventors

Rainer Albert · Basel, CH
Nigel Graham Cooke · Oberwil, CH
Sylvain Cottens · Witterswil, CH
Claus Ehrhardt · Lörrach, DE
Jean-Pierre Evenou · La Valette-du-Var, FR
Richard Sedrani · Basel, CH
Peter Von Matt · Biel-Benken, CH
Jurgen Wagner · Bottmingen, CH
Gerhard Zenke · Rheinfelden (Baden), DE

Key dates

Filing date	Feb 20, 2007
Grant date	Nov 2, 2010
Priority date	—
Expiry date	Feb 20, 2027

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D471/10
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Indolylmaleimide derivatives comprising either a substituted phenyl, naphthyl, tetrahydronaphthyl, quinazolinyl, quinolyl, isoquinolyl or pyrimidinyl residue have interesting pharmaceutical properties, e.g. in the treatment and/or prevention of T-cell mediated acute or chronic inflammatory diseases or disorders, autoimmune diseases, graft rejection or cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.